Authors
Zhiyong He, Jennifer H McDaniel, Linhua Tian, Mahir Mohiuddin, Ningchun Xu, Lili Wang, Sheng Lin-Gibson, Justin M Zook, Hua-Jun He
Published in
Molecular therapy. Advances. Volume 34. Issue 4. Pages 201873. Dec 10, 2026. Epub Oct 21, 2026.
Abstract
Characterizing proviral insertions in chimeric antigen receptor (CAR)-T cells is critical for cell therapy product safety and efficacy. We generated clonal CD19 CAR-T cell lines designated VCN1-VCN5 based on RRE copies per cell measured by droplet digital PCR (ddPCR). Some clones also contained additional partial vector-derived integrations not reflected in this designation. Short- and long-read whole-genome sequencing (WGS) were used for characterizing the insertions. Long reads proved essential, fully resolving each insertion and revealing that only 3 of 10 insertions matched the expected sequence. The remainder exhibited structural variants and/or abnormalities. One particularly important structural abnormality resolved only by long reads is a 724-bp deletion of the EF-1α promoter disrupting expression of the CD19 CAR. Standard short-read and ddPCR approaches miss this deletion due to this promoter being in the unengineered human genome. These results demonstrate that these cell lines are suitable VCN candidate reference standards for 1-5 copies of full proviral DNA insertions (VCN4 and VCN5 harboring an extra E GFP copy) and highlight the utility of long-read sequencing in characterizing both quantity and quality of insertions in lentiviral-engineered cells.
PMID:
43034636
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0